InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the complete record of transactions filed by Botwood Nicholas A.J.. Officer active across 2 companies, notably Syndax Pharmaceuticals Inc. Aggregated, 6 filings have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €95k. History available since 16 May 2025. The latest transaction was filed on 4 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Botwood Nicholas A.J. is a declarant linked to Syndax Pharmaceuticals Inc, where the listed role is Head of R&D, CMO. He has 6 filings in total, and in the recent filings tracked, the period runs from 2025-05-19 to 2026-06-12, with EUR 94549 of buys and EUR 0 of sells, and the most frequent transaction nature is Levée d'options.